Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating DWP14012 for maintaining healing in subjects with healed erosive esophagitis is ongoing; no results or status disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Healed Erosive Esophagitis | Phase 3 | Status: UNKNOWN